Thomas Kung
Impact in
-
- Chemotherapy-induced cardiotoxicity and mitigation
- Cardiovascular Function and Risk Factors
- Heart Failure Treatment and Management
-
- Nutrition and Health in Aging
- Adipose Tissue and Metabolism
Papers in
-
- Chemotherapy-induced cardiotoxicity and mitigation 2
- Atrial Fibrillation Management and Outcomes 1
-
- Pulmonary Hypertension Research and Treatments 2
- Lung Cancer Treatments and Mutations 1
- Co-authors
- Wolfram Doehner (8 shared papers)Stephan von Haehling (7 shared papers)Stefan D. Anker (4 shared papers)Jochen Springer (3 shared papers)Anja Sandek (4 shared papers)Tibor Szabó (3 shared papers)Stefan D. Anker (2 shared papers)Bert Hildebrandt (2 shared papers)
In The Last Decade
Thomas Kung
12 papers receiving 338 citations
Peers
Comparison fields: 5 of 45
- Cardiology and Cardiovascular Medicine 126
- Physiology 125
- Transplantation 6
- Nephrology 12
- Complementary and alternative medicine 14
Countries citing papers authored by Thomas Kung
This map shows the geographic impact of Thomas Kung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Kung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Kung more than expected).
Fields of papers citing papers by Thomas Kung
This network shows the impact of papers produced by Thomas Kung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Kung. The network helps show where Thomas Kung may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Kung, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 86 | |
| 2 | 2013 | 58 | |
| 3 | 2013 | 42 | |
| 4 | 2010 | 41 | |
| 5 | 2011 | 39 | |
| 6 | 2009 | 32 | |
| 7 | 2011 | 27 | |
| 8 | 2013 | 13 | |
| 9 | 2018 | 2 | |
| 10 | 1984 | 2 | |
| 11 | 1987 | 1 | |
| 12 | 2019 | 1 |
About Thomas Kung
Thomas Kung is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Physiology, Surgery and Molecular Biology, having authored 12 papers that have together received 344 indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (2 papers), Chemotherapy-induced cardiotoxicity and mitigation (2 papers), Nutrition and Health in Aging (2 papers), Atrial Fibrillation Management and Outcomes (1 paper), Nitric Oxide and Endothelin Effects (1 paper), Venous Thromboembolism Diagnosis and Management (1 paper), Lung Cancer Research Studies (1 paper) and Lung Cancer Treatments and Mutations (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (126 citations), Physiology (125 citations), Transplantation (6 citations), Nephrology (12 citations) and Complementary and alternative medicine (14 citations). Thomas Kung has collaborated with scholars based in Germany, Italy and Hong Kong. Frequent co-authors include Wolfram Doehner, Stephan von Haehling, Stefan D. Anker, Jochen Springer, Anja Sandek, Tibor Szabó, Stefan D. Anker, Bert Hildebrandt, Nadja Scherbakov and Miroslava Valentová. Their work appears in journals such as Journal of the American College of Cardiology, Archives of Medical Science, Nutrition Metabolism and Cardiovascular Diseases, Journal of Cachexia Sarcopenia and Muscle and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.